ARCHIVES

FDA Committee Can’t Find “Reasonable” Evidence Alkylating Agent Clinical Use Is Carcinogenic

This article is from The Cancer Letter archive.

Vol. 02 No. 37 | September 10, 1976

Download PDF Visit The Full Archive

Related Articles

AACI Asks NCI to Reconsider Dropping CCPDS Support, Find New Mechanism to Fund Center Outreach Effort

July 9, 1982

NCI Commits $8 Million More to R01s, Increases Payline to 12th Percentile. Surgeon General’s Report Says There’s No Safe Level of Secondhand Smoke.

June 30, 2006

Jill ElkenberryTo Get ACCC Award

March 17, 1989

Griesmer To Leave NTP, Will Return To Oak Ridge

March 28, 1980

FDA Delays Decision On Avastin Approval For Breast Cancer

September 24, 2010

Senate Appropriators Plan Hearing On NCI Ouster Of Fisher

June 3, 1994